Novavax, Inc. (NVAX)
8.86
-0.08
(-0.89%)
USD |
NASDAQ |
Aug 24, 16:00
8.86
0.00 (0.00%)
After-Hours: 20:00
Novavax Price : 8.86 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 8.87 | 8.98 | 8.26 | 8.86 | 5.579M |
| Aug 21, 2026 | 8.44 | 9.200 | 8.435 | 8.94 | 10.45M |
| Aug 20, 2026 | 8.50 | 8.66 | 8.02 | 8.42 | 5.976M |
| Aug 19, 2026 | 8.43 | 8.83 | 8.19 | 8.79 | 11.45M |
| Aug 18, 2026 | 7.97 | 8.08 | 7.835 | 7.93 | 2.015M |
| Aug 17, 2026 | 8.05 | 8.17 | 7.95 | 8.07 | 1.928M |
| Aug 14, 2026 | 8.13 | 8.13 | 7.915 | 8.05 | 2.280M |
| Aug 13, 2026 | 8.01 | 8.23 | 7.92 | 8.14 | 3.507M |
| Aug 12, 2026 | 7.91 | 7.99 | 7.83 | 7.96 | 2.542M |
| Aug 11, 2026 | 7.92 | 8.03 | 7.78 | 7.95 | 2.607M |
| Aug 10, 2026 | 7.892 | 7.96 | 7.695 | 7.89 | 3.225M |
| Aug 07, 2026 | 7.75 | 8.086 | 7.595 | 7.95 | 5.704M |
| Aug 06, 2026 | 7.825 | 7.908 | 7.532 | 7.74 | 4.903M |
| Aug 05, 2026 | 7.71 | 7.755 | 7.54 | 7.70 | 3.633M |
| Aug 04, 2026 | 7.49 | 7.70 | 7.455 | 7.66 | 3.249M |
| Aug 03, 2026 | 7.37 | 7.610 | 7.26 | 7.41 | 2.580M |
| Jul 31, 2026 | 7.44 | 7.49 | 7.215 | 7.32 | 3.406M |
| Jul 30, 2026 | 7.43 | 7.505 | 7.25 | 7.44 | 2.926M |
| Jul 29, 2026 | 7.31 | 7.465 | 7.235 | 7.34 | 2.327M |
| Jul 28, 2026 | 7.485 | 7.535 | 7.15 | 7.37 | 2.869M |
| Jul 27, 2026 | 7.76 | 7.82 | 7.49 | 7.49 | 3.319M |
| Jul 24, 2026 | 7.90 | 7.930 | 7.45 | 7.46 | 3.178M |
| Jul 23, 2026 | 7.83 | 7.91 | 7.72 | 7.825 | 2.389M |
| Jul 22, 2026 | 8.14 | 8.180 | 7.87 | 7.91 | 2.637M |
| Jul 21, 2026 | 7.91 | 8.13 | 7.87 | 8.075 | 2.530M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 138.89 |
| Merck & Co., Inc. | 150.66 |
| Pfizer Inc. | 27.97 |
| Recursion Pharmaceuticals, Inc. | 3.25 |
| Agenus, Inc. | 7.67 |
Price Related Metrics
| PS Ratio | 3.508 |
| Earnings Yield | -17.19% |
| Market Cap | 1.460B |